Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.
暂无分享,去创建一个
E. Venkatraman | M. Zelefsky | S. Leibel | Z. Fuks | A. Hummer | M. Katz | Zvi Fuks | Steven A Leibel | Michael J Zelefsky | Matthew S Katz | Ennapadam S Venkatraman | Amanda Hummer
[1] R. B. Smith,et al. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. , 1994, The Journal of urology.
[2] M. Anscher,et al. Multivariate analysis of factors predicting local relapse after radical prostatectomy--possible indications for postoperative radiotherapy. , 1991, International journal of radiation oncology, biology, physics.
[3] S. Levitt,et al. Delayed/salvage radiation therapy in patients with elevated prostate specific antigen levels after radical prostatectomy: A long term follow‐up , 1996 .
[4] D. Cox. Regression Models and Life-Tables , 1972 .
[5] R. Vessella,et al. Issues in the assessment of PSA immunoassays. , 1993, The Urologic clinics of North America.
[6] P. Carroll,et al. Radiation therapy for the management of biopsy proved local recurrence after radical prostatectomy. , 1998, The Journal of urology.
[7] W. Catalona,et al. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment. , 1994, The Journal of urology.
[8] E. B. Butler,et al. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] C. Catton,et al. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] J. Forman,et al. Impact of postprostatectomy prostate-specific antigen nadir on outcomes following salvage radiotherapy. , 1998, Urology.
[11] P. Schellhammer,et al. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. Ornstein,et al. Evaluation and management of men whose radical prostatectomies failed: results of an international survey. , 1998, Urology.
[13] J W Moul,et al. Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy. , 2000, The Journal of urology.
[14] R A Stephenson,et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. , 2000, JAMA.
[15] J. Cadeddu,et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. , 1998, The Journal of urology.
[16] S. Schild,et al. The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy. , 1996, The Journal of urology.
[17] T. Stamey,et al. Positive surgical margins at radical prostatectomy: importance of the apical dissection. , 1990, The Journal of urology.
[18] T. Stamey,et al. Incontinence and vesical neck strictures following radical retropubic prostatectomy. , 1995, Urology.
[19] F. Vicini,et al. Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. , 1999, Urology.
[20] D W Hillman,et al. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer. , 2000, The Journal of urology.
[21] E. Bergstralh,et al. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? , 2001, The Journal of urology.
[22] C B Begg,et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.
[23] A. D'Amico,et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.
[24] M. Zelefsky,et al. Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy. , 1997, International journal of radiation oncology, biology, physics.
[25] Colin B Begg,et al. Variations in morbidity after radical prostatectomy. , 2002, The New England journal of medicine.
[26] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[27] J. Smith,et al. Postoperative radiation therapy for pathologic stage C prostate cancer. , 1987, International journal of radiation oncology, biology, physics.
[28] P. Carroll,et al. Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns. , 1999, Urology.
[29] T. J. Robnett,et al. PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients , 2000, International journal of cancer.
[30] M. Bagshaw. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer , 1998, International journal of radiation oncology, biology, physics.
[31] N. Sanfilippo,et al. Preirradiation PSA predicts biochemical disease-free survival in patients treated with postprostatectomy external beam irradiation. , 1997, International journal of radiation oncology, biology, physics.
[32] P. Carroll,et al. Use of second treatment following definitive local therapy for prostate cancer: data from the caPSURE database. , 1998, The Journal of urology.
[33] J. Forman,et al. Predicting the need for adjuvant systemic therapy in patients receiving postprostatectomy irradiation. , 1996, Urology.
[34] J. Epstein,et al. Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression? , 1997, The Journal of urology.
[35] A W Partin,et al. Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.
[36] J. Forman,et al. Definitive radiotherapy following prostatectomy: results and complications. , 1986, International journal of radiation oncology, biology, physics.
[37] J. Dekernion,et al. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. , 1997, The Journal of urology.
[38] M S Anscher,et al. Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years. , 2000, International journal of radiation oncology, biology, physics.
[39] H. Scher. Management of prostate cancer after prostatectomy: treating the patient, not the PSA. , 1999, JAMA.
[40] P. Carroll,et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. , 2000, The Journal of urology.
[41] E. Venkatraman,et al. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[42] A. Partin,et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. , 1996, The American journal of surgical pathology.
[43] S. Cha,et al. Irradiation for locally recurrent carcinoma of the prostate following radical prostatectomy. , 1997, Urology.
[44] A. Partin,et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. , 1994, Urology.
[45] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[46] D. Bostwick,et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma , 1999, Cancer.
[47] A. Zietman,et al. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[48] Baba,et al. Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy , 1999, Prostate cancer and prostatic diseases.
[49] P. Carroll,et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. , 1995, International journal of radiation oncology, biology, physics.
[50] R. Valicenti,et al. Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose. , 1998, Urology.
[51] L. Sullivan,et al. Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control. , 1996, The Journal of urology.